Methylmalonic acidemia with homocystinuria
|
[MIM 277 380, 277 400, 277 410, 614 857]
See also Cobalamin, congenital deficiency of
Rare: 1/60,000 for the most common form (cblC). Autosomal recessive transmission; Metabolic disorder due to an anomaly in the metabolism of vitamin B12.
Clinical signs:
- megaloblastic anemia
- lethargy
- failure to thrive
- intellectual deficiency
- epilepsy
The possible genotypes and phenotypes are:
1) combined adenosyl - and methyl-cobalamin deficiency:
- cobalamin F: LMBRD1 gene mutation (6q13); first signs during the 1st year: developmental delay, megaloblastic anemia or pancytopenia, stomatitis
- cobalamin C: the most frequent (1/100,000). mutation of the MMACHC gene (1p36.3); signs (acute) in the 1St month or the 1era year: leads to methylmalonic aciduria and homocystinuria, sometimes a hemolytic uremic syndrome (see these terms); some forms tend to become clinically apparent lately (10 %): psychiatric problems, progressive encephalopathy, convulsions
- cobalamin D: very rare; mutation of the MMADHC gene (2q23.2); results in methylmalonic aciduria or homocystinuria (see these terms)
- cobalamin J: gene ABCD4
2) adenosylcobalamin deficiency: cbla and cblb mutations which cause methylmalonic aciduria (see this term) close to the secondary methylmalonyl-CoA deficiency phenotype. Mutation of the MMAA (4q31.1-q31.2) or MMAB (12q24) gene. Treatment: protein restriction and intake of vitamin B12
3) methylcobalamin deficiency: cble and cblg mutations; extremely rare; first signs in the 1st year: megaloblastic anemia and neurological disorders (developmental delay, hypo - or hypertonia, ataxia, seizures, homocystinuria) mutation of MTRR (5p15.2-15.3) or MTR (1q43) gene. Treatment: vitamin B12 and betaine.
Anesthetic implications:
check complete blood count; avoid using N2O in the presence of methylmalonic aciduria (see this term)
References :
Updated January 2019